The tariff classification of Lamivudine (CAS-134678-17-4), imported in bulk form; and EPIVIR® Tablets, EPIVIR® Oral Solution, EPIVIR®-HBV™ Tablets, and EPIVIR®-HBV™ Oral Solution imported put up in measured doses or in forms or packings for retail sale, from the United Kingdom, France, Italy, Canada, Singapore, etc.
Reasoning
The tariff classification of Lamivudine (CAS-134678-17-4), imported in bulk form; and EPIVIR® Tablets, EPIVIR® Oral Solution, EPIVIR®-HBV™ Tablets, and EPIVIR®-HBV™ Oral Solution imported put up in measured doses or in forms or packings for retail sale, from the United Kingdom, France, Italy, Canada, Singapore, etc.
Cite this ruling
CBP Ruling F85881 (2934904700): The tariff classification of Lamivudine (CAS-134678-17-4), imported in bulk form; and EPIVIR® Tablets, EPIVIR® Oral Solution, EPIVIR®-HBV™ Tablets, and EPIVIR®-HBV™ Oral Solution imported put up in measured doses or in forms or packings for retail sale, from the United Kingdom, France, Italy, Canada, Singapore, etc.
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293490
Protest No. 1001-00-103199; Ademetionine Sulfate Tosylate
The tariff classification of 2-Chloronicotinic Acid (CAS 2942-59-8) from France.
The tariff classification of N-6-Benzoyl Adenosine from Switzerland
The tariff classification of 2-Mercaptobenzoxazole (CAS 2382-96-9) from France.
The tariff classification of Leflunomide (CAS-75706-12-6), imported in bulk form, from India, and Raloxifene Hydrochloride (CAS-82640-04-8), imported in bulk form, from Italy